SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001171843-17-005762
Filing Date
2017-09-28
Accepted
2017-09-28 11:05:07
Documents
2
Period of Report
2017-09-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT formthree.html 3  
1 OWNERSHIP DOCUMENT formthree.xml 3 1538
2 EXHIBIT 24.1 exh_241.htm EX-24.1 7051
  Complete submission text file 0001171843-17-005762.txt   9991
Mailing Address 4233 TECHNOLOGY DR DURHAM NC 27704
Business Address 4233 TECHNOLOGY DR DURHAM NC 27704 9192876300
ARGOS THERAPEUTICS INC (Issuer) CIK: 0001105533 (see all company filings)

IRS No.: 562110007 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1715 VERRAZZANO DRIVE WILMINGTON NC 28405
Business Address
MORRISON RICHARD G (Reporting) CIK: 0001222906 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35443 | Film No.: 171106181